Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v9-FR
Language English French
Date Updated 2019-11-20 2019-11-19
Drug Identification Number 02382326 02382326
Brand name HEPARIN SODIUM INJECTION USP HEPARIN SODIUM INJECTION USP
Common or Proper name HEPARIN SODIUM INJECTION USP HEPARIN SODIUM INJECTION USP
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients HEPARIN SODIUM HEPARIN SODIUM
Strength(s) 10000UNIT 10000UNIT
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS
Packaging size 25 x 1mL GVL 25 x 1mL GVL
ATC code B01AB B01AB
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-11 2019-10-11
Estimated end date
Actual end date 2019-11-19 2019-11-19
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments